GSK Researchers Identify Potential Target for Therapeutics to Promote MS Remyelination
News
Researchers at GlaxoSmithKline (GSK) have identified the histamine receptor 3 (H3R) as a potential new therapeutic target for promoting remyelination in patients with multiple sclerosis (MS). Their study ... Read more